Overview
The provided abstracts do not specifically address the definition, diagnosis, or management of diabetes mellitus in remission. They focus on pharmacologic treatments for established type 2 diabetes and general diabetes management 12.Diagnosis
The provided abstracts do not contain information regarding diagnostic criteria or recommended tests for diabetes mellitus in remission 12.Management
The provided abstracts do not outline specific management strategies for diabetes mellitus in remission. Abstract 1 details newer pharmacologic treatments for adults with type 2 diabetes, including glucagon-like peptide-1 (GLP-1) agonists, GLP-1 agonist and glucose-dependent insulinotropic polypeptide (GIP) agonists, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and long-acting insulins 1. Abstract 2 discusses general therapeutic management of diabetes and glycemic complications 2.Special Populations
The provided abstracts do not cover diabetes mellitus in remission for specific populations such as pregnancy, pediatrics, or the elderly. Abstract 1 focuses on adults with type 2 diabetes, and Abstract 2 addresses diabetes management in wilderness athletes 12.Key Recommendations
The provided abstracts do not offer specific recommendations pertaining to diabetes mellitus in remission 12.References
1 Qaseem A, Obley AJ, Shamliyan T, Hicks LA, Harrod CS, Crandall CJ et al.. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians. Annals of internal medicine 2024. link 2 VanBaak KD, Nally LM, Finigan RT, Jurkiewicz CL, Burnier AM, Conrad BP et al.. Wilderness Medical Society Clinical Practice Guidelines for Diabetes Management. Wilderness & environmental medicine 2019. link